$369.00
-10.99-2.89%
Last update: Nov 5, 4:00 PM
Bio-Rad Laboratories Inc
BIONYSE
Bio-Rad Laboratories (BIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Bio-Rad Laboratories (BIO) last issued guidance on November 4, 2026 for fiscal year 2026. The company guided revenue in the range of $2.51B - $2.6B for the period.
Compared to prior guidance, Bio-Rad Laboratories maintained its revenue forecast from a prior range of $2.51B - $2.6B.
Bio-Rad Laboratories has issued 16 guidance updates between February 16, 2023 and November 4, 2026. During this period, the company raised its outlook 2 times and lowered it 6 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $2.30 | $1.86 | $2.14 | $2.65 |
| Actual | $2.65 | $2.62 | $1.89 | $2.51 |
| Surprise | +15.2% | +40.9% | -11.7% | -5.28% |
| Revenue | ||||
| Estimate | $652.3M | $630.7M | $587.4M | $689.9M |
| Actual | $656.4M | $651.0M | $592.1M | $693.2M |
| Surprise | +0.62% | +3.23% | +0.80% | +0.48% |
| Metric | Q4 '26E | Q1 '27E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $2.93 | $2.83 |
| Revenue | ||
| Consensus | $698.0M | $611.3M |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $2.65 | $2.30 | 15.2 % |
| Q2 | Aug 4, 2026 | $2.62 | $1.86 | 40.9 % |
| Q1 | Apr 30, 2026 | $1.89 | $2.14 | -11.7 % |
| Q4 | Feb 12, 2026 | $2.51 | $2.65 | -5.28 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $656.40M | $652.33M | 0.62 % |
| Q2 | Aug 4, 2026 | $651.00M | $630.66M | 3.23 % |
| Q1 | Apr 30, 2026 | $592.10M | $587.38M | 0.80 % |
| Q4 | Feb 12, 2026 | $693.20M | $689.87M | 0.48 % |
